Амбулаторное лечение пациентов с синдромом хронической усталости, астеническим синдромом и синдромом вегетативной дистонии: опыт применения Ван Би
Амбулаторное лечение пациентов с синдромом хронической усталости, астеническим синдромом и синдромом вегетативной дистонии: опыт применения Ван Би
Т.Т.Батышева, Л.В.Багирь, Е.В.Костенко, И.Ю.Артемова, Т.В.Вдовиченко, П.А.Ганжула, Е.Ю.Журавлева, А.М.Исмаилов, Л.Н.Лисенкер, О.В.Нестерова, О.В.Отческая, Л.Д.Ротор, А.А.Хозова, А.Н.Бойко. Амбулаторное лечение пациентов с синдромом хронической усталости, астеническим синдромом и синдромом вегетативной дистонии: опыт применения Ван Би. Consilium Medicum. Неврология (Прил.). 2008; 1: 100-104.
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Список литературы
1. Клебанова В.А. Синдром хронической усталости (обзор). Гигиена и санитария. 1995; 1: 144–8.
2. Babbar PO, Joshi MN, Madan AR. Evaluation of plants for antiviral
activity. lnd. J Med Res 1982; 76: 54–6.
3. Bahr V, Hansel R. Immunomodulating properties of 5,20 0-dihydroxy-6,7-epoxy-l-oxo (5) with a 2,24-dienolide and solasodine. Planta
Medica 1982; 44: 32.
4. Batra A, Mehta BK Chromatographic analysis and antibacterial
activity of the seed oil of Argyreia speciosa. Fitoterapia 1985; 6: 357–9.
5. Bhattacharya SK, Sanyal AK. Curariform activity of some Indian
medicinal plants. Nagarjun 1969; 13(2): 19.
6. Bhattacharya SK, Goel RK, Kaur R, Ghoshal S. Anti-Stress activity of
Sitoindesides VII and VIII, New cylsteryglycosides from Withianisa Somnifera.
Phytotherapy Res 1987; 1(1): 32–7.
7. Brekhman II, Dadymov IV. New substances of plant origin which
increase non specific resistance. Ann Rev Pharacol Toxicol 1969; 9: 419.
8. Dange PS, Kanitkar UK, Pendre GS. Amylase and lipase activities in
the roots of Asparagus racemosus. Planta Med 1969; 17: 393.
9. Dhar ML, Dhar MM, Dhawan BN et al. Screening of Indian plants for
biological activity. Ind J Exp Biol 1968; 6: 232.
10. Ghosal S et al. Phytotherapy Res 1989; 3(5): 201–6.
11. Kapoor LD. CRC Handbook of ayurvedic medicinal plants. CRC Press; Florida, 1990.
12. Kiritkar KR, Basu BD. lndian Medical Plants: Vol. Ill, Periodical export Book Agency. India, 1984.
13. Krivol LR. Chronic fatigue syndrome. Pediatr Ann 1995; 24: 290–2.
14. Kulshreshtha VK, Srivastava RK, Singh N, Kohil RP. A study of central
stimulant effect of Piper longum. Ind J Pharmacol 1969; 1(2): 8.
15. Kuppurajan S. Effect of Ashwagandha (Withania somnifera) on the
process of ageing in human volunteers. J Res Ayur Siddha 1980; 1(2): 247–56.
16. Lawrie SM et al. Chronic fatigue syndrom in community. Prevalence
and associations. Br J Psychiatry 1995; 166: 793–7.
17. Mason JW. A historical view of the stress field Il. J Human Stress 1975; 1: 22.
18. McKenzie R et al. Chronic fatigue syndrome. Adv Intern Med 1995; 40: 119–53.
19. Murtagh J. Patient education: chronic fatigue syndrome. Aust Fam Physician 1995; 24: 1297.
20. Pant MC, Uddin I, Bharadwaj UR, Tewari RD. Blood sugar of total cholesterol lowering effect of glycine soja, Mucuna pruriens DC and Dolichos biflorus Linn. Seed diets in normal fasting albino rats. Ind J Med Res 1968; 56: 18.
21. Przewlocka M. Chronic fatigue syndrome. Pol Tyg Lek 1994; 49: 593–5.
22. Ramaswamy S, Nazeemudin SK, Vishwanathan S et al. Some pharmacological effects of Mucuna pruriens. Proc M.M.C. Res Soc 1979; 2: 39.
23. Roy RN, Chavan SR, Bhargava S et al. Preliminary pharmacological studies on different extracts of roots of Asparagus racemosus (Shatavari) Wild. Ind J Pharm 1968; 30: 289.
24. Seyle H. The evolution of stress concept. Am Scientist 1973; 63: 692.
25. Schonfeld U. Chronic fatigue syndrome. Med Monatsschr Pharm
1995; 18: 90–6.
26. Sharma AK, Singh RH. Screening of anti-inflammatory activity of certain indigenous drugs on carrageening induced hind paw oedema in rats. Bull Med Ethnobot Res 1980; 2: 262.
27. Shobat B, Kirson I, Lavie D. Immunodepressive properties of Withaferin and Withanolide D. Biomedicine 1978; 28: 18.
28. Singh RH, Malaviya PC. Studies on the psychotropic effect of Indian
indigenous drug Ashwagandha (Withania somrtifera) Part II experimental
studies. J Res Ind Med Yoga Homeo 1979; 14(1): 49–54.
29. Singh RH, Malaviya PC, Sarkar HF, Udupa KN. Studies on the psychotropic
effect of Indian indigenous drug Ashwagandha (Withania Somnifera) Part 1 Clinical studies. J Res Ind Med Yog Homeo 1978; 14(l): 15–24.
30. Srivastava MC, Kant V, Tewari JP. Anti-inflammatory activity of roots of Argyreria speciosa. Mediscope 1972; 15: 219–22.
31. Swannik CM et al. Chronic fatigue syndrome: a clinical and laboratory
study with a well matched control group. J Int Med 1995; 237: 499–506.
32. Wessely S. The epidemiology of chronic fatigue syndrome. Epid Rev1995; 17: 139–51.
33. Ziem G et al. Chronic fatigue syndrome, fibromyalgia and chemical
sensitivity overlapping disorders. Arch Intern Med 1995; 155: 1913.
2. Babbar PO, Joshi MN, Madan AR. Evaluation of plants for antiviral
activity. lnd. J Med Res 1982; 76: 54–6.
3. Bahr V, Hansel R. Immunomodulating properties of 5,20 0-dihydroxy-6,7-epoxy-l-oxo (5) with a 2,24-dienolide and solasodine. Planta
Medica 1982; 44: 32.
4. Batra A, Mehta BK Chromatographic analysis and antibacterial
activity of the seed oil of Argyreia speciosa. Fitoterapia 1985; 6: 357–9.
5. Bhattacharya SK, Sanyal AK. Curariform activity of some Indian
medicinal plants. Nagarjun 1969; 13(2): 19.
6. Bhattacharya SK, Goel RK, Kaur R, Ghoshal S. Anti-Stress activity of
Sitoindesides VII and VIII, New cylsteryglycosides from Withianisa Somnifera.
Phytotherapy Res 1987; 1(1): 32–7.
7. Brekhman II, Dadymov IV. New substances of plant origin which
increase non specific resistance. Ann Rev Pharacol Toxicol 1969; 9: 419.
8. Dange PS, Kanitkar UK, Pendre GS. Amylase and lipase activities in
the roots of Asparagus racemosus. Planta Med 1969; 17: 393.
9. Dhar ML, Dhar MM, Dhawan BN et al. Screening of Indian plants for
biological activity. Ind J Exp Biol 1968; 6: 232.
10. Ghosal S et al. Phytotherapy Res 1989; 3(5): 201–6.
11. Kapoor LD. CRC Handbook of ayurvedic medicinal plants. CRC Press; Florida, 1990.
12. Kiritkar KR, Basu BD. lndian Medical Plants: Vol. Ill, Periodical export Book Agency. India, 1984.
13. Krivol LR. Chronic fatigue syndrome. Pediatr Ann 1995; 24: 290–2.
14. Kulshreshtha VK, Srivastava RK, Singh N, Kohil RP. A study of central
stimulant effect of Piper longum. Ind J Pharmacol 1969; 1(2): 8.
15. Kuppurajan S. Effect of Ashwagandha (Withania somnifera) on the
process of ageing in human volunteers. J Res Ayur Siddha 1980; 1(2): 247–56.
16. Lawrie SM et al. Chronic fatigue syndrom in community. Prevalence
and associations. Br J Psychiatry 1995; 166: 793–7.
17. Mason JW. A historical view of the stress field Il. J Human Stress 1975; 1: 22.
18. McKenzie R et al. Chronic fatigue syndrome. Adv Intern Med 1995; 40: 119–53.
19. Murtagh J. Patient education: chronic fatigue syndrome. Aust Fam Physician 1995; 24: 1297.
20. Pant MC, Uddin I, Bharadwaj UR, Tewari RD. Blood sugar of total cholesterol lowering effect of glycine soja, Mucuna pruriens DC and Dolichos biflorus Linn. Seed diets in normal fasting albino rats. Ind J Med Res 1968; 56: 18.
21. Przewlocka M. Chronic fatigue syndrome. Pol Tyg Lek 1994; 49: 593–5.
22. Ramaswamy S, Nazeemudin SK, Vishwanathan S et al. Some pharmacological effects of Mucuna pruriens. Proc M.M.C. Res Soc 1979; 2: 39.
23. Roy RN, Chavan SR, Bhargava S et al. Preliminary pharmacological studies on different extracts of roots of Asparagus racemosus (Shatavari) Wild. Ind J Pharm 1968; 30: 289.
24. Seyle H. The evolution of stress concept. Am Scientist 1973; 63: 692.
25. Schonfeld U. Chronic fatigue syndrome. Med Monatsschr Pharm
1995; 18: 90–6.
26. Sharma AK, Singh RH. Screening of anti-inflammatory activity of certain indigenous drugs on carrageening induced hind paw oedema in rats. Bull Med Ethnobot Res 1980; 2: 262.
27. Shobat B, Kirson I, Lavie D. Immunodepressive properties of Withaferin and Withanolide D. Biomedicine 1978; 28: 18.
28. Singh RH, Malaviya PC. Studies on the psychotropic effect of Indian
indigenous drug Ashwagandha (Withania somrtifera) Part II experimental
studies. J Res Ind Med Yoga Homeo 1979; 14(1): 49–54.
29. Singh RH, Malaviya PC, Sarkar HF, Udupa KN. Studies on the psychotropic
effect of Indian indigenous drug Ashwagandha (Withania Somnifera) Part 1 Clinical studies. J Res Ind Med Yog Homeo 1978; 14(l): 15–24.
30. Srivastava MC, Kant V, Tewari JP. Anti-inflammatory activity of roots of Argyreria speciosa. Mediscope 1972; 15: 219–22.
31. Swannik CM et al. Chronic fatigue syndrome: a clinical and laboratory
study with a well matched control group. J Int Med 1995; 237: 499–506.
32. Wessely S. The epidemiology of chronic fatigue syndrome. Epid Rev1995; 17: 139–51.
33. Ziem G et al. Chronic fatigue syndrome, fibromyalgia and chemical
sensitivity overlapping disorders. Arch Intern Med 1995; 155: 1913.
Авторы
Т.Т.Батышева1,3, Л.В.Багирь1, Е.В.Костенко1, И.Ю.Артемова4, Т.В.Вдовиченко4, П.А.Ганжула4, Е.Ю.Журавлева4, А.М.Исмаилов4,
Л.Н.Лисенкер4, О.В.Нестерова4, О.В.Отческая4, Л.Д.Ротор4, А.А.Хозова4, А.Н.Бойко2
1. Поликлиника восстановительного лечения №7 УЗ ЦАО;
2. Кафедра неврологии и нейрохирургии РГМУ;
3. Кафедра неврологии МГМСУ;
4. Окружные неврологические отделения УЗАО Москвы
Л.Н.Лисенкер4, О.В.Нестерова4, О.В.Отческая4, Л.Д.Ротор4, А.А.Хозова4, А.Н.Бойко2
1. Поликлиника восстановительного лечения №7 УЗ ЦАО;
2. Кафедра неврологии и нейрохирургии РГМУ;
3. Кафедра неврологии МГМСУ;
4. Окружные неврологические отделения УЗАО Москвы
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.